Medical Network Sp. z o.o. — Clinical Trial Site

102 Registered trials

50 Currently recruiting

Organisation

Medical Network Sp. z o.o.

Location

Warsaw, Poland

Identifier

ORG-100049896

Address

Ul. Plowiecka 103, 04-501, Poland

Departments

"Medical Network Sp. z o. o. WIP Warsaw IBD Point Profesor Kierkuś"
#PL10004: Gastrology
4803-MEDICAL NETWORK Sp. z o.o., WIP Warsaw IBD Point Profesor Kierkuś
Gastroenterology
Gastroenterology Department
Medical Network Spolka z o.o. WIP Warsaw IBD Point Profesor Kierkus
Medical Network Spółka z o. o. WIP Warsaw IBD Point
N/A
NA
PL0008: gastroenterology
PL10022: Medical Network Sp. z o. o. WIP Warsaw IBD Point Profesor Kierkus
PL10028: Medical Network Sp. z o. o. WIP Warsaw IBD Point Profesor Kierkus
PL10042: Medical Network Sp. z o. o. WIP Warsaw IBD Point Profesor Kierkus
PL10048_WIP Warsaw IBD Point Profesor Kierkus
Site Name: WIP Warsaw IBD Point Profesor Kierkus/ ul. Płowiecka 103, 04-501 Warszawa
TBC
WIP IBD Point Jarosław Kierkuś
WIP Warsaw IBD Point
WIP Warsaw IBD Point Prof. Kierkuś
WIP Warsaw IBD Point Profesor Kierkus
WIP Warsaw IBD Point Profesor Kieruś
WIP Warsaw IBD Point Professor Kierkuś
WIP Warsaw IBD Profesor Kierkuś

Clinical trials at this site (102)

Search interface

A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending

2025-521037-86-00 Immune system diseases 5
A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti… Pending

2025-521038-27-00 Immune system diseases 5
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending

2025-521590-13-00 Moderately to Severely Active Crohn’s Disease 5
A study to evaluate safety and explore efficacy of new lipase NHS7108 compared with pancrelipase in adult participants with exocrine pancre… Pending

2025-521816-20-00 Exocrine Pancreatic Insufficiency 4
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indicat… Pending

2025-522362-78-00 severely active ulcerative colitis (US) and CD (Crohn’s 6
A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative co… Pending

2025-522511-42-00 Crohn's disease 4
An Early-Stage Study in Multiple Clinics of how Afimkibart May Affect the Body’s Processing of Medicines that Rely on Cytochrome P450 Enzyme… Pending

2025-524060-38-00 Active Ulcerative Colitis (UC) 3
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease Recruiting

2025-522001-38-00 Crohn’s Disease 4 2026-05-27
A Study to Test a New Drug in Adults With Moderate to Severe Ulcerative Colitis Recruiting

2025-524719-35-00 Ulcerative Colitis 9 2026-05-22
A Study of how the Medicine Called "Etrasimod" Works in Children With the gut Disease Called Ulcerative Colitis Recruiting

2025-523100-77-00 Ulcerative Colitis 4 2026-04-23
Essentiale® liquid once-daily Phase III study Recruiting

2025-521678-32-00 MASLD (Metabolic Dysfunction-Associated Steatotic Liver 5 2026-03-03
A Multi-Stage Study to Test a New Drug in Healthy Adult Volunteers, Then in Adults with Ulcerative Colitis Recruiting

2025-522702-21-00 Ulcerative Colitis is a type of inflammatory bowel dise 4 2026-01-26
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY) Recruiting

2025-521797-34-00 Diabetes Mellitus, Type 1 5 2026-01-20
Vedolizumab Subcutaneous Long-term Open-label Extension Study in Pediatric Subjects Recruiting

2023-508804-39-00 Ulcerative Colitis or Crohn’s Disease 5 2025-10-15
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Recruiting

2024-518296-56-00 Crohn’s Disease 5 2025-09-29
A study to investigate efficacy and safety of brivekimig in participants with Crohn’s disease Recruiting

2024-517016-30-00 Crohn’s disease 4 2025-09-26
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obe… Recruiting

2024-520209-38-00 Obesity or Overweight 5 2025-09-19
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Co… Recruiting

2024-520201-39-00 Moderately to Severely Active Ulcerative Colitis 4 2025-08-28
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting

2023-507853-13-00 Ulcerative Colitis 4 2025-02-25
Phase 3 Study of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Recruiting

2023-503188-40-00 Active Ulcerative Colitis or Crohn’s Disease 5 2025-01-06
Study of GS-1427 in Participants With Moderately to Severely Active UC Recruiting

2023-508304-38-00 Ulcerative Colitis (UC) 4 2024-09-10
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with a… Recruiting

2023-509606-30-00 Ulcerative colitis 5 2024-07-24
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants with Eosinophilic Gastritis with or without Eosinophilic Duod… Recruiting

2022-500795-62-00 Eosinophilic gastritis 4 2024-03-25